|
Originally published In Press as doi:10.1074/jbc.M004541200 on July 20, 2000
J. Biol. Chem., Vol. 275, Issue 40, 31245-31254, October 6, 2000
The Structural Basis of DNA Target Discrimination by
Papillomavirus E2 Proteins*
Seung-Sup
Kim,
Jeffrey K.
Tam,
Ai-Fei
Wang, and
Rashmi S.
Hegde
From the Department of Biochemistry and Program in Structural
Biology, New York University Medical Center, Skirball Institute of
Biomolecular Medicine, New York, New York 10016
Received for publication, May 25, 2000, and in revised form, July 11, 2000
 |
ABSTRACT |
The papillomavirus E2 proteins regulate the
transcription of all papillomavirus genes and are necessary for viral
DNA replication. Disruption of the E2 gene is commonly associated with
malignancy in cervical carcinoma, indicating that E2 has a role in
regulating tumor progression. Although the E2 proteins from all
characterized papillomaviruses bind specifically to the same 12-base
pair DNA sequence, the cancer-associated human papillomavirus E2
proteins display a unique ability to detect DNA flexibility and
intrinsic curvature. To understand the structural basis for this
phenomenon, we have determined the crystal structures of the human
papillomavirus-18 E2 DNA-binding domain and its complexes with
high and low affinity binding sites. The E2 protein is a dimeric
-barrel and the E2-DNA interaction is accompanied by a large
deformation of the DNA as it conforms to the E2 surface. DNA
conformation and E2-DNA contacts are similar in both high and low
affinity complexes. The differences in affinity correlate with the
flexibility of the DNA sequence. Preferences of E2 proteins from
different papillomavirus strains for flexible or prebent DNA targets
correlate with the distribution of positive charge on their DNA
interaction surfaces, suggesting a role for electrostatic forces in the
recognition of DNA deformability.
 |
INTRODUCTION |
Networks of hydrogen bonds between amino acid side chains and the
functional groups of DNA bases are a well documented mechanism of DNA
sequence recognition by proteins. Not as well understood is the
stereochemical and energetic basis by which protein-DNA binding
affinity is modulated when all of these direct components of
interaction are conserved. Biologically, such discriminatory abilities
are essential when DNA-binding proteins have to select between multiple
binding sites present among a vast excess of nonspecific DNA. This is
the case in the papillomaviruses, where the primary transcriptional
regulatory protein, E2, is confronted by numerous binding sites on the
viral genome (Fig. 1a). These sites must be occupied in a
defined order such that transcription and viral DNA replication proceed
in a regulated fashion (1-7).
The papillomaviruses are a large family of double-stranded DNA viruses
that vary in host species specificity, tissue tropism, and the clinical
outcome of infection (8, 9). The E2 protein has the same functions in
the over 100 characterized papillomavirus strains: to activate or
repress transcription in a context-dependent fashion and to
facilitate the initiation of viral DNA replication via interactions
with the viral replication protein E1. Differences in the details of
transcription and replication control have been documented between the
viral strains that infect different host tissues and between the
papillomavirus strains that are associated with different conditions in
humans such as warts or cervical cancer (2-7). The E2 proteins from
all viral strains have in common the fact that they bind a palindromic
DNA sequence ACCgNNNNcGGT, referred to as the E2 binding site
(E2BS;1 lowercase letters
indicate preferred nucleotides, and the NNNN region is called the
"spacer"). However, there exist virus strain-specific differences
in the abilities of various E2 proteins to discriminate between binding
sites. The E2 proteins from the human papillomavirus (HPV) strains that
infect mucosa (including the cancer-associated strains HPV-18 and
HPV-16 and the wart-causing strain HPV-11) bind with significantly
greater affinity to E2BS with spacers rich in AT base pairs (1,
10-12). On the other hand, the E2 protein from bovine papillomavirus
type 1 (BPV-1) displays no distinctive spacer sequence preference (12).
The viral genomes reflect these trends; the mucosal HPV genomes have E2
binding sites with AT-rich spacers (Fig.
1a), while the genomes of the nonprimate animal viruses (including BPV-1) have no such predominance of AT-rich spacer-containing binding sites (13). The crystal structures
of the E2 DNA-binding domain from strains BPV-1 (14), HPV-16 (15), and
HPV-31 (16) have been reported, as has the co-crystal structure of
BPV-1 E2 bound to DNA (17). However, there is no structural information
yet on a DNA complex of any HPV E2 protein. Here we report the crystal
structures of the E2 DNA-binding domain (E2/D) from human
papillomavirus type 18 and its complexes with high and low affinity
binding sites.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 1.
a, structure of the HPV-18 genome. The
7857-base pair circular genome consists of two regions coding for early
(E) and late (L) genes. An 800-base pair
noncoding region is present upstream of the E6 gene and is called the
long control region (LCR). The major early promoter
(P105) and a differentiation-specific promoter are
indicated by arrows. The long control region contains both
transcriptional regulatory elements and the origin of replication. A
region of the long control region (of HPV strains 18, 16, 11, and
31) that contains the four E2 binding sites (E2BS1-4) is detailed
below. In each case, the spacer sequence is shown in
blue. The inset is the consensus DNA-binding site
of the E2 proteins and the sequences of the two binding-sites referred
to as E2BS(AATT) and E2BS(ACGT). The identity elements are in
red, and the preferred nucleotides are in green.
b, amino acid sequence alignments of the HPV-18, HPV-16, and
BPV-1 E2 DNA-binding domains. Identical residues are in red,
and similar residues are in green. The residue numbering for
HPV-18 E2 and BPV-1 E2 are shown as is the secondary structure of
HPV-18 E2/D. The arrows represent -strands, and
zigzag lines indicate helices. c,
ribbon diagram of the HPV-18 E2 DNA-binding domain.The two
subunits (gold and lavender) associate to form an eight-stranded
antiparallel -barrel. Disordered regions are represented by
dotted lines. The topology is shown
beside them. The -barrel is formed by curling the
figure toward the viewer such that the 2
strands at the edges can form hydrogen bonds with each other. The
ribbon diagram was generated by RIBBONS
(42).
|
|
The HPV-18 E2-DNA interaction uses an induced-fit mechanism, with a
large deformation of DNA and only modest local rearrangements of the
protein. Comparisons of the various E2/D structures reveal an
unexpected similarity between the quaternary structures of the HPV-18
and BPV-1 E2/D proteins as compared with those of the more closely
related (in sequence, evolutionary distance of viral strain, and
pathology) HPV-16 and HPV-31 E2/D proteins. HPV-18 E2/D binds with very
different affinities to the two E2BS sequences used in the
crystallographic studies, yet no base sequence-specifying protein-DNA
contacts differ in the two complexes. Like the related HPV-16 E2/D
protein, but in contrast to BPV-1 E2/D, HPV-18 E2/D recognizes and
discriminates against conformational flexibility in DNA.
There exists a correlation between the distribution of positive charge
on the DNA interaction surfaces of these proteins and their preferences
for prebent or flexible DNA targets.
 |
EXPERIMENTAL PROCEDURES |
Protein and Oligonucleotide Preparation
His-tagged HPV-18 E2/D (amino acids 286-365 and N-terminal
residues GSHM that arose from the cloning procedure) was obtained by
overexpression in Escherichia coli strain BL21(DE3)pLysS.
The His-tagged protein was purified by nickel affinity chromatography. The His tag was removed by thrombin treatment, and the cleaved protein
was further purified by ion exchange chromatography (Fast-S; Amersham
Pharmacia Biotech), resulting in pure protein as determined by
silver-stained SDS gels. BPV-1 E2/D was purified as described previously (17). All oligonucleotides were obtained from the Yale Keck
Biotechnology Facility and purified by ion exchange chromatography
(Mono-Q; Amersham Pharmacia Biotech) (17).
Crystallizations
All of the crystals were grown by vapor diffusion from hanging
drops at room temperature.
HPV-18 E2/D--
5 mg ml 1 of HPV-18
E2/D in 25 mM Tris, pH 7.5, 100 mM NaCl,
10 mM DTT was mixed with an equal volume of a reservoir
solution containing 2.7 M ammonium sulfate and 0.1 M sodium acetate, pH 4.7. Crystals of dimensions 0.25 × 0.25 × 0.15 mm appeared in 3-5 days. Diffraction data were
recorded on a RAXIS II image plate detector from a crystal maintained
at 170 °C.
HPV-18 E2/D-E2BS(AATT)--
An equimolar mixture of HPV-18 E2/D
and E2BS(AATT) was made in 25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM DTT. Drops were made by mixing
10 mg ml 1 complex with an equal volume of a
reservoir solution containing 47% 2-methyl-2,4-pentane diol,
100 mM sodium acetate, pH 4.7, 20 mM
CaCl2. Platelike crystals of dimensions 0.4 × 0.25 × 0.05 mm appeared in 5-7 days. Diffraction data were
recorded on a RAXIS II image plate detector from a crystal maintained
at 170 °C.
HPV-18 E2/D-E2BS(ACGT)--
An equimolar mixture of HPV-18 E2/D
and E2BS(ACGT) was made in 25 mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM DTT. Drops containing equal
volumes of the protein-DNA complex and a well solution containing 48%
2-methyl-2,4-pentane diol, 100 mM sodium acetate, pH
4.7, 20 mM CaCl2 were made. Very thin platelike
crystals (0.1 × 0.1 × 0.02 mm) appeared in 5-7 days.
Diffraction data were recorded at Brookhaven beam X4A on a CCD detector
from a crystal maintained at 170 °C.
BPV-1 E2/D-E2BS(AATT)--
An equimolar mixture of BPV-1 E2/D
and an annealed oligonucleotide of sequence CCAACCGAATTCGGTTG was made
in 25 mM Tris, pH 7.5, 100 mM NaCl, 10 mM DTT. Drops were made with 6.25 mg
ml 1 of the complex and an equal volume of a
reservoir solution containing 30% PEG3350, 47 mM MES, pH
6.2, 2 mM CaCl2. Rod-shaped crystals of
dimensions 0.15 × 0.1 × 0.08 mm appeared in 5-7 days.
Diffraction data were recorded on a RAXIS II image plate detector from
a crystal maintained at 170 °C.
Structure Solution and Refinement
All images were indexed; the reflections were integrated,
scaled, and postrefined with the HKL package (programs DENZO and SCALEPACK (18)); and the structures were determined by molecular replacement using the program AMORE (19).
A model of BPV-1 E2/D-E2BS(ACGT) (17) was used to find a Molecular
Replacement solution for the BPV-1 E2/D-E2BS(AATT) structure. Using
data from 15-3.5 Å, the correct solution had a correlation coefficient of 0.25.
A polyalanine model constructed from the refined structure of the BPV-1
E2/D-E2BS(AATT) complex was used in Molecular Replacement to determine
the structure of the HPV-18 E2/D-E2BS(AATT) complex. Using data from
15-4.8 Å, the correct solution had a correlation coefficient of
0.491.
A model consisting of one subunit of HPV-18 E2/D was constructed from
the HPV-18 E2/D-E2BS(AATT) complex structure and used to obtain a
Molecular Replacement solution for the HPV-18 E2/D structure. Using
data between 15 and 4.5 Å, the correct solution had a correlation
coefficient of 0.507.
Using the refined structure of the E2BS(AATT) complex as a model, rigid
body refinement was conducted on the HPV-18 E2/D-E2BS(ACGT) complex
data. Using difference maps, the correct oligonucleotide sequence was modeled.
All structures (except the HPV-18 E2/D-E2BS(ACGT) complex) were refined
using a combination of simulated annealing, bulk solvent correction,
positional refinement, and restrained individual B-factor refinement in
CNS (20). Simulated annealing omit maps were systematically calculated
and examined to minimize the effects of model bias. Only restrained
grouped B-factors were refined for the HPV-18 E2/D-E2BS(ACGT) structure.
The final model of HPV-18 E2/D-E2BS(AATT) includes residues 287-323
and 329-364 (residues 309-312 had weak electron density, and some of
these side chains were modeled as Ala). No unambiguous density
corresponding to the C-terminal residue (Met365) was
present, and it is not included in the refined model.
In three out of four subunits that comprise the asymmetric unit, the
final model of HPV-18 E2/D includes residues 287-322 and 329-365
(residues 308-312 had weak electron density, and these side chains
were modeled as Ala). One subunit had clear density corresponding to
residues 323-328, which are included in the model. Since crystal
packing influences this region, the loop conformation is not included
in any discussions.
The final model of HPV-18 E2/D-E2BS(ACGT) includes residues 287-323
and 328-364 (residues 310-312 had weak electron density, and some of
these side chains were modeled as Ala). No unambiguous density
corresponding to the C-terminal residue (Met365) was
present, and it is not included in the refined model.
The final model of BPV-1 E2/D-E2BS(AATT) includes residues 326-410.
There are two complexes in the asymmetric unit. In one complex, one
5'-overhanging C is flipped out packing against the protein surface,
and no density corresponding to the other 5'-C is present. In the other
complex, the C nucleotide at position 8 of one strand is flipped out
and packed against the protein surface. The 5'-C then base pairs with
G+8 of the other strand. Since the DNA conformation at the
5'- and 3'-ends are clearly affected by crystal packing, all analyses of DNA conformation in the discussions are restricted to the central 14 base pairs that include the E2BS.
For all structures, the final model had all non-Gly residues in allowed
regions of the Ramachandran plot. The data and refinement statistics
are summarized in Table I. A section of a
composite simulated annealing omit map calculated on the HPV-18
E2/D-E2BS(AATT) co-crystal structure is shown in Fig.
2.

View larger version (99K):
[in this window]
[in a new window]
|
Fig. 2.
Stereoview of a simulated annealing omit
2Fo-Fc map of the HPV-18 E2/D-E2BS(AATT) complex.
A section of the recognition helix in the DNA major
groove is shown. The map was calculated at 2.3-Å resolution and is
contoured at 1.5 . The image was generated by the Swiss
PDB viewer.
|
|
DNA Binding Studies
The oligonucleotides were
engineered so that the termini of the DNA were either at one end or
within the spacer region (Table II and Fig.
3) of the E2 binding site. This strategy
allowed the introduction of breaks in the phosphodiester backbone of
the E2 binding site. Oligonucleotides were purified by acrylamide gel electrophoresis, end-labeled, and annealed by heating the probe (2 nM concentration) to 90 °C for 10 min and transferring
immediately to ice for 10 min. Quantitative gel mobility shift
experiments were conducted following published protocols (21, 22).
Briefly, serial dilutions of the proteins were added to binding buffer resulting in a final mixture containing 2 nM
-32P-labeled oligonucleotide, 150 µg/ml bovine serum
albumin, 5 µg/ml sonicated salmon sperm DNA, 5.5 mM DTT,
22 mM HEPES, pH 7.9, 150 mM KCl, 5 mM MgCl2, and 10% (v/v) glycerol. The reaction
mixtures were incubated in a water bath at 25 °C for 30 min and then
loaded onto prerun 12% polyacrylamide gels in 0.5× TBE, pH 8.0. The
electrophoresis was run at 200 V for ~90 min. The gels were dried and
the reaction products visualized by exposure to phosphor storage
plates, which were scanned using a PhosphorImager (Molecular Dynamics,
Inc., Sunnyvale, CA).
View this table:
[in this window]
[in a new window]
|
Table II
Equilibrium binding constants for HPV-18 E2/D
The design of oligonucleotides used in these experiments is shown in
Fig. 3. Hairpin oligonucleotides of the sequence shown in (Fig.
3a) were used to determine the affinity of HPV-18 E2/D for
E2BS with the spacer sequences indicated in the first section.
Dumb-bell shaped oligonucleotides (Fig. 3b) were used to
introduce nicks in the phosphodiester backbone of the DNA probe.
|
|
The density of the electrophoretic band representing the protein-DNA
complex was quantitated using the ImageQuant software. Binding
isotherms were obtained by monitoring the density of the electrophoretic band representing the protein-DNA complex as a function of protein concentration and analyzed by nonlinear
least-squares analysis. The equilibrium binding constant, K,
was determined by analysis of the titration curves against the coupled
equations
|
(Eq. 1)
|
and
|
(Eq. 2)
|
where 1 is the DNA fraction unbound,
2 is the DNA fraction complexed with protein,
K is the equilibrium association constant, and [X] is the
free active protein dimer concentration. The DNA binding activity of
the HPV-18 E2/D protein preparations was determined from stoichiometric
titrations (22); the values presented are corrected for this activity.
Since the -32P-labeled oligonucleotide concentration is
much lower than the equilibrium dissociation constants being measured,
the approximation that total protein concentration is equal to free
protein concentration is made. The standard state Gibbs free energy of
binding was calculated from the equilibrium association constant by
G0 = RT ln K,
where R is the gas constant and T is temperature. Each of the values of G0 reported were
determined by the global analysis of at least two independent titrations.
 |
RESULTS |
Overview of the Structures--
The 1.9-Å crystal structure of
HPV-18 E2/D and the 2.4-Å structure of its complex with the high
affinity binding site E2BS(AATT) are described in detail below. In
order to examine the stereochemistry at a low affinity HPV-18 E2/D-DNA
interface, the structure of HPV-18 E2/D bound to E2BS(ACGT) has been
determined. While the limited resolution (3 Å) of this crystal
structure does not permit detailed analyses, it is of sufficient
quality to allow comparisons of global features and direct protein-DNA
interactions. To provide a direct comparison between the modes of DNA
recognition of the HPV-18 and BPV-1 E2/D proteins, the 2.3-Å structure
of BPV-1 E2/D bound to E2BS(AATT) has also been determined. This
complex is similar in most respects to the previously reported crystal
structure of BPV-1 E2/D bound to E2BS(ACGT) (17), and only salient
features are presented here. In all of the discussions below,
comparisons are drawn between the complexes of the HPV-18 or BPV-1 E2/D
proteins with the same E2BS sequence, unless explicitly stated otherwise.
The HPV-18 E2 DNA-binding Domain--
Each monomer of HPV-18 E2/D
folds into an open-faced -sandwich with a - - - - -
topology (Fig. 1c). One -helix in each subunit contains
all of the amino acid residues involved in half-site recognition and is
termed the "recognition helix." Two E2/D monomers associate such
that the -strands at the edges ( 2 and
4) form hydrogen bonds with their symmetry mates (Fig.
1c). This results in a continuous eight-stranded
antiparallel -sheet. Buried in the interface are numerous large side
chains including Thr287, Ile289,
His291, Lys293, Trp320,
Trp322, Ile332, Thr334,
Thr336, Met363, and Met365 (Fig.
4a). The dimerization
interface is extensive, occluding 1625 Å2 of surface area.
A herring bone type packing of four Trp residues in the dimer interface
is common to all of the mucosal HPV E2 proteins (Fig. 4) and is likely
to be a major contributor to the stability of the dimer. As a result of
the intricate and closely packed dimer interface, any rearrangement of
subunits upon DNA binding would entail a significant energetic penalty.
There is a cavity at the center of the barrel, and solvent molecules
have been modeled into the electron density clearly apparent in this region. Electron density corresponding to the loop between the recognition helix and 2 (residues 308-312) is weak,
indicating local disorder in this region. The loop between strands
2 and 3 is disordered.

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 4.
Stereoviews of the dimer interfaces of HPV-18
E2/D (a) and HPV-16 E2/D (b).
The backbone is represented as a coil, and side chains that
occupy the barrel interior are shown. A solvent molecule bridging the
His290 residues in HPV-16 E2/D is shown as a
sphere. Hydrogen bonds formed between side chain atoms in
HPV-18 E2/D are shown as dotted lines.
Images were generated by ICM (43).
|
|
Comparison of the Structures of E2 Proteins from Different Viral
Strains--
The E2 proteins from different viral strains differ in
quaternary structure (Fig.
5a). The HPV-18 and BPV-1 E2/D
proteins are alike in the relative orientation of their subunits while differing from the HPV-16 and HPV-31 E2/D proteins. When one subunit of
each protein is superimposed, the nonsuperimposed recognition helices
of HPV-16 and HPV-18 E2/D are related by an average translation of 7 Å (Fig. 5a). Functionally, these features of the E2 proteins are critical, since they dictate the spatial arrangement of side chains
presented to the major grooves for DNA sequence recognition. The large
variation in subunit orientation among the HPV E2/D proteins suggests
either that they undergo unique subunit rearrangements upon DNA binding
or that DNA is bent very differently in each of the protein-DNA
complexes.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
a, comparison of the structures of
HPV-18 E2/D (gray) and HPV-16 E2/D (black). The
left subunit of each protein has been superimposed to highlight the
differences in quaternary structure. Images were generated
by GRASP (44). b, alignment of symmetry-related
4 strands in HPV-18 E2/D, HPV-16 E2/D, and BPV-1 E2/D.
The panels are placed relative to each other as in the
superimposition of protein dimers in Fig. 3a, with the
top strand in each case corresponding to the
superimposed subunit. Side chains of residues that participate in
-sheet-stabilizing interactions are shown. Also shown are the side
chains of Tyr362 in HPV-18 E2/D and Phe362 in
HPV-16 E2/D, which do not participate in -sheet-stabilizing
interactions. The arrows indicate the direction of the
-strands.
|
|
E2 dimer architecture is governed by two features: first, the alignment
of strands 2 and 4 against their symmetry
mates (Fig. 5b) and, second, the packing of side chains in
the barrel core (Fig. 4). While the alignment of the 2
strands is invariant, E2 proteins from different viral strains differ
in the register of their dyad-related 4 strands (Fig.
5b). When one subunit each of the HPV-18 E2/D and HPV-16
E2/D proteins are superimposed, residues
Gly361-Thr364 of HPV-18 E2/D align with
residues Gly361-Ser364 of HPV-16 E2/D. The
nonsuperimposed subunit is out of register by two residues;
Tyr362-Met365 of HPV-18 E2/D lines up with
Thr360-Met363 of HPV-16 E2/D. As a result,
while the Phe362 residues of HPV-16 E2/D straddle a 2-fold
axis, the corresponding Tyr362 residues in HPV-18 E2/D are
not symmetrically disposed about a 2-fold axis. In this regard,
HPV-18 E2/D resembles BPV-1 E2/D, while the HPV-16 and HPV-31 E2/D
proteins are similar to each other (23). It has been proposed that
strand register is specified by cross-strand side chain interactions
(24), and this is clearly evident in the case of these E2/D proteins.
The invariant glycine in the 4 strand of all E2 proteins
(Gly361 in HPV-18 E2/D and HPV-16 E2/D and
Gly403 in BPV-1 E2/D) has the potential to destabilize the
-sheet. In HPV-18 E2/D, the -sheet is disrupted at
Gly361, with the side chain of Thr364
participating in a cross-strand hydrogen bond while the -strands diverge. In BPV-1 E2/D, the side chain of Phe410
participates in a cross-strand rescue of the
Gly403-mediated -sheet destabilization. Such pairing of
glycine and aromatic residues across -strands provides an increase
in protein stability (25). The aromatic side chains of
Tyr362 in HPV-18 and Phe362 in HPV-16 E2/D do
not participate in analogous cross-strand stabilization. Thus, the
surfaces formed by the 4 strands of different E2/D proteins are not alike. Interestingly, this surface of BPV-1 E2 has
been implicated in an interaction with the E1 helicase that is
essential for viral DNA replication (26). The differences in structure
described above could contribute to the inability of heterologous E1
and E2 proteins (from different viral strains) to interact with each
other (27).
The core of the -barrel is densely packed in all E2 proteins. A
common feature of the HPV-16 E2/D and HPV-31 E2/D dimer interfaces is
the presence of an ordered solvent molecule bridging two histidine residues (His290 from 1 of HPV-16 E2/D; Fig.
4). No such bridging molecule is present in either free or DNA-bound
HPV-18 E2/D. Instead, the corresponding His291 side chain
participates in an intrasubunit hydrogen-bonding network that also
includes residues Trp320, Thr334, and
Thr364 (Fig. 4). Despite these differences in
oligomerization, both HPV-18 E2/D and HPV-16 E2/D bury similar surface
areas (1625 Å2 for HPV-18 E2/D and 1553 Å2
for HPV-16 E2/D), approximately 70% of which is nonpolar.
The HPV-18 E2/D-DNA Complex--
DNA surrounds one face of the
HPV-18 E2/D -barrel engulfing both recognition helices in successive
major grooves (Fig. 6a). The
global structure of the HPV-18 E2/D protein is similar in its free and
DNA-bound states with a root mean square deviation of 1.1 Å for the
peptide backbone of the dimer. There is a very small adjustment of
recognition helix orientation that facilitates symmetric placement of
the helices in contact with the identity elements of the E2BS. On
average, the temperature factors of recognition helix backbone atoms
are lowered by 11 Å2 upon DNA interaction, indicating that
the helices assume more rigid conformations as a network of protein-DNA
interactions is formed.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 6.
a, comparison of the HPV-18 E2/D protein
in the free (green) and DNA-bound (gold) states.
The left subunit is superimposed. b, comparison of
the complexes formed by HPV-18 E2/D (gold) and BPV-1 E2/D
(blue) with E2BS(AATT). The left subunit of each protein is
superimposed. c, the intersubunit interactions between side
chains in the 2/ 3 loop and the C-terminal
region of the recognition helix in the BPV-1 E2/D-E2BS(AATT) complex.
The backbone worm representing relevant regions of the two subunits are
shown in different colors.
|
|
HPV-18 E2/D-DNA binding is not accompanied by any large
disorder-to-order transition. In particular, the disordered loop
connecting 2 and 3 is not
conformationally restricted upon DNA binding. In contrast, DNA binding
significantly rigidifies the corresponding segments of the BPV-1 E2/D
protein; six intersubunit hydrogen bonds and two tethering contacts
with DNA phosphate oxygens contribute to this stabilization (Fig.
6c).
DNA Conformation in the E2-DNA Complexes--
DNA wraps around the
outside surface of the E2 -barrel, tracing a smooth curve. The
overall bend angle was measured between normals to the base pairs at
positions +6 and 6 from the dyad axis, thus encompassing the
consensus E2BS and eliminating any effects of end-to-end lattice
packing (Table III). The bend angle is
very similar for the HPV-18 E2/D and BPV-1 E2/D complexes with both
E2BS sequences studied. The DNA is the B form with compressed major and
minor grooves facing the protein. Three local parameters, roll, helix
twist, and slide, that are the most sensitive to DNA deformation were
analyzed and are listed in Table III. The roll angles in the contacted
ACC/GGT half-sites are positive, thus compressing the major groove, and
the roll angles in the central NNNN region are negative, compressing
the minor groove. No kink at any single base step is observed. The DNA
axis traces an out-of-plane bend. In all cases, the central four base
pairs are overtwisted, while the ACCG/CGGT half-sites are
underwound.
View this table:
[in this window]
[in a new window]
|
Table III
Local DNA parameters
Local DNA parameters roll, twist, and slide were calculated using
FREEHELIX (45). These parameters were calculated with
respect to the local axis of the base pair step. Parameters
corresponding to the spacer region of the E2BS are in boldface type.
DNA parameters for the BPV-1 E2/D-E2BS(ACGT) complex were calculated
from 2bop.pdb. Minor groove widths were calculated from the shortest
P-P distances across the groove. Bend angles were measured between
normal and base pairs at positions +6 and 6 from the dyad axis.
|
|
The complexes formed by the HPV-18 and BPV-1 E2/D proteins differ in
two related respects: the central minor groove width and the roll angle
at the central dinucleotide step. The central minor groove is narrower
in the HPV-18 E2/D complexes (8.5 Å) than it is in the BPV-1 E2/D
complexes (9.8 Å), regardless of spacer sequence. A large negative
roll angle of 11.4° at the central dinucleotide step of the HPV-18
E2/D- E2BS(AATT) complex contributes to this narrowing of the minor
groove. No classical spine of hydration is apparent in the minor groove
of any E2-DNA complex. The complex between BPV-1 E2/D and E2BS(ACGT)
has a more positive slide in the central AT step than all the other
complexes. This results in a deepening of the central minor groove.
In summary, both E2 proteins induce a similar global deformation of DNA
characterized by compressed major and minor grooves at the interaction
surface. The trends in roll angle and groove width are characteristic
of the particular E2 protein present in the complex. Since both HPV-18
E2/D and BPV-1 E2/D must induce the same overall deformation in DNA,
any differences in their preferences for intrinsic DNA conformational
propensities must reflect differences in their innate abilities to
stabilize the appropriate distortion.
Half-site Recognition by HPV-18 E2/D--
Each recognition helix
of HPV-18 E2/D lies along the floor of a DNA major groove and presents
numerous side chains to the exposed edges of the bases (Fig.
7a). Recognition of the
minimal E2 binding site sequence ACCNNNNNNGGT is mediated by a network of hydrogen bonds (Fig. 7b) comparable with those seen in
the BPV-1 E2/D-E2BS(AATT) complex (Fig. 7d). Specifically,
residues Asn297, Lys300, and Cys301
of HPV-18 E2/D make direct hydrogen bonds with bases at positions 4-6.
These interactions are symmetric about the dyad axis defined by the
palindromic DNA sequence. Additionally, Arg305 contacts the
adenine base at position 7 outside the minimal E2BS. This interaction
may contribute to the 16-fold greater affinity with which HPV-18 E2/D
binds to sites that have an AT base pair at this location
(e.g. BS2 versus BS1 in the HPV-18 genome (1) (Fig. 1a)). Mutagenesis data show that an Arg305
to Ala mutation abrogates this specificity (28). HPV-18 E2/D also
contacts the phosphodiester backbone of the DNA in both the major and
the minor grooves. In total, 14 direct and 20 water-mediated phosphate
contacts have been identified. Phosphate contacts made by
Thr319, Arg303, and Ser298 at
positions 3, 4, and 7 of the DNA have exact counterparts in the BPV-1
E2-DNA complex via residues Thr359, Arg342, and
Gln337. Thus, all major groove phosphate contacts are
conserved between these two complexes. The minor groove phosphate
contact made by Arg296 is unique to the HPV-18 E2/D- DNA
complex. Notably absent from the HPV-18 E2/D-DNA complexes is any
contact between phosphates and amino acids in the
2/ 3 loop, such as that mediated by the Arg370 side chain of BPV-1 E2/D.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 7.
a and c, view of the
recognition helices of HPV-18 E2/D (a) and BPV-1 E2/D
(c) as positioned in the major groove of DNA. Side chains of
amino acids involved in direct contacts with the bases are shown.
Hydrogen bonds are indicated by dashed lines.
b and d, schematic drawings of the protein-DNA
contacts observed in the HPV-18 E2/D complex with E2BS(AATT)
(b) and BPV-1 E2/D complex with E2BS(AATT) (d).
Base pairs in the absolutely conserved identity elements are depicted
by filled rectangles, and preferred base pairs
are shown as gray rectangles. Phosphates
contacted by the proteins are shown as gray-filled circles.
Circles labeled W represent solvent molecules.
The hatched line represents a hydrophobic van der
Waal's contact. All of the interactions are dyad symmetric; however,
in these images base contacts are shown in the
bottom half and phosphate contacts in the
top half.
|
|
All of the direct protein-DNA contacts described above are present in
the low affinity complex between HPV-18 E2/D and E2BS(ACGT). Although
solvent molecules were not modeled, clear electron density is present
at positions in the interface where solvent-mediated protein-DNA
contacts are seen in the high affinity E2BS(AATT) complex.
Noncontacted Spacer Sequence Preferences of HPV-18
E2/D--
The affinity of HPV-18 E2/D toward a representative set of
E2BS that differed in spacer sequence was measured. These included the
spacer sequences found on the HPV-18 genome and those used in the
crystallographic analyses reported here. The results are presented in
Table II. HPV-18 E2/D binds with greater affinity to E2BS containing
AT-rich spacer sequences. The relationship between binding affinity and
spacer sequence can be summarized as AATT > AAAT > AAAA > TTAA ACGT. Similar preferences for AT-rich spacer
sequences were reported for HPV-16 E2/D and HPV-11 E2/D (10, 12). The
co-crystal structures reported here eliminate the possibility that
direct contact with the bases is responsible for the ability of HPV-18
E2/D to discriminate between E2BSs based upon their spacer sequence.
A-tract-containing binding sites would be predisposed to adopt the
narrowed central minor groove conformation found in the E2-DNA complex
(29), thus lowering the enthalpic cost of DNA deformation upon E2
binding. Conversely, E2BS that are not conformationally complementary
to the protein surface would bind to E2 with lower affinity, reflecting
the distortion free energy of the DNA as it assumes the conformation
found in the complexed state. This is clearly evident in the nearly 2 kcal/mol greater affinity of HPV-18 E2/D for E2BS(AATT) than for
E2BS(TTAA). While both of these binding sites have AT-rich spacer
sequences, the TpA step in E2BS(TTAA) rolls into the major groove,
resulting in central minor groove widening (30), a conformation
not complementary to the E2 DNA-binding surface. A similar
widening of the central minor groove was seen in the crystal structure
of free E2BS(ACGT) (31), toward which HPV-18 E2/D also displays low
affinity. The AT-rich spacer sequence preference of the HPV E2 proteins
thus correlates with the conformational complementarity of such
intrinsically curved DNA to the E2 surface.
Although BPV-1 E2/D also distorts DNA in a globally analogous fashion,
it does not show any significant preference for AT-rich spacer-containing E2BS (12). Two differences between the HPV-18 and
BPV-1 E2/D-DNA complexes may contribute to this effect. First, the
central minor groove is not as narrow in BPV-1 E2/D-DNA complexes as it
is in the HPV-18 E2/D-DNA complexes (Table III). Thus, a predisposition
toward narrow minor grooves may be less important for the BPV-1
E2/D-DNA interaction. Second, Arg370 in the
2/ 3 loop of BPV-1 E2 makes a critical
phosphate interaction in the central minor groove of the DNA. This
contact could significantly attenuate repulsion between phosphate
groups on the two strands caused by minor groove narrowing. The spacer
sequence preferences of HPV-18 E2/D may reflect its inability to
compensate for this electrostatic repulsion between the strands of a
narrowed minor groove.
In order to explore the relationship between DNA flexibility and HPV-18
E2/D binding, we measured the affinity of HPV-18 E2/D toward
representative nicked E2BS sequences (Table II). HPV-18 E2/D binds with
significantly lower affinity to a nicked E2BS(AATT) target than it does
to the corresponding intact oligonucleotide. In contrast, upon
introducing a nick in a DNA target that is not conformationally
complementary to the E2 DNA-binding surface (E2BS(TTAA)), the affinity
of the interaction is slightly enhanced. It appears that HPV-18 E2/D
discriminates against flexibility in the E2BS. In a more exhaustive
analysis, it was shown that HPV-16 E2/D-DNA binding affinity was also
drastically attenuated when the flexibility of the E2BS was increased
via nicks in the phosphodiester backbone (12). Further support for the
conclusion that these HPV E2 proteins discriminate against flexibility
in their DNA targets comes from an analysis of DNA deformability (32),
which suggests that A runs (of 3 or more A nucleotides) are more
deformable than AA dimers. This correlates with the greater affinity
exhibited by HPV-18 E2/D for E2BS(AATT) than for E2BS(AAAT) or
E2BS(AAAA). DNA flexibility can reduce the energy expended in deforming
DNA upon ligand or protein binding, but it also increases the entropic cost in going from a flexible, free DNA to a relatively rigid complexed
state. The fact that the HPV E2/D-DNA interaction is adversely affected
by flexibility in DNA indicates that the entropic cost is not balanced
by favorable protein-DNA interactions. Interestingly, the BPV-1 E2
protein does not disfavor flexibility in the E2BS (12), suggesting that
the DNA-bending mechanisms of these E2 proteins may be dissimilar.
Furthermore, in the case of the E. coli phage 434 repressor-operator interactions (33, 34), where a preference for
AT-rich spacer sequences was also observed, the repressor-DNA
interaction was favored by DNA flexibility. Thus, no general
relationship between DNA flexibility and protein binding affinity has
yet been derived.
There is a substantial difference in the distribution of positive
potential on the DNA contact surfaces of HPV-18 E2/D and BPV-1 E2/D
(Fig. 8). A large accumulation of
positive charge is present in the central region of HPV-18 E2/D, which
is juxtaposed against the minor groove of the E2BS (Fig.
8a). This is primarily due to the basic residues
Arg296, Arg303, and Arg307.
According to finite difference Poisson-Boltzmann analyses, the DNA
minor groove potentials are more negative for ApT sequences than they
are for GpC sequences. This is because the electrostatic potentials on
T(O2) and A(N3) atoms are more negative than
the corresponding values for C(O2) and G(N3)
(35). E2BS with AT-rich spacer sequences thus have minor grooves that
are electrostatically complementary to the HPV-18 E2/D surface.
Interestingly, HPV-16 E2/D does not have a similar accumulation of
positive charge at the center of its DNA-binding surface (15), yet it
too prefers AT-rich spacer-containing binding sites (11, 12). Thus the spacer sequence discrimination ability of HPV-16 E2/D may rely less on
simple electrostatic complementarity than in the case of HPV-18 E2/D.
In contrast to both of these HPV E2/D proteins, positive charge on
BPV-1 E2/D is concentrated on surfaces flanking the E2BS (Fig.
8b), correlating with its inability to favor binding sites
with AT-rich spacer sequences. Thermodynamic and structural studies are
in progress to critically assess the relationships between
electrostatics, DNA flexibility, and the mechanism of E2/D-DNA
binding.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 8.
The potential energy surfaces presented to
DNA by HPV-18 E2/D and BPV-1 E2/D. The electrostatic surface
potential of the HPV-18 E2 DNA-binding domain (a) and
the BPV-1 E2 DNA-binding domain (b) was calculated by GRASP
(44). Negative potentials are red; positive potentials are
blue. Water probe radius was 1.4 Å; potential is displayed
on a 15 kBT to +15
kBT scale. The view is that shown in
c. The disordered 2/ 3 loop is
indicated by a dotted line, and the recognition
helices are in blue.
|
|
 |
DISCUSSION |
Viral DNA replication and gene expression patterns reflect the
relative occupancy of E2 binding sites as the concentration of the E2
protein varies (1, 36, 37). The mucosal HPVs have a conserved
arrangement of four E2BS on their genomes (Fig. 1a). E2
binding at BS4 can specifically up-regulate viral early gene
expression, including the expression of oncogenes E6 and E7. E2 binding
at the promoter-proximal sites BS1 and BS2 leads to repression of
transcription of the early genes, including the oncogenes E6 and E7.
E2BS3 is important for viral DNA replication.
Papillomaviruses replicate in terminally differentiated cells that have
exited the cell cycle. Since viral DNA replication is dependent on host
cell factors, they need to activate the transcription of the E6/E7
genes. The expressed E6 and E7 proteins can then bind and inactivate
two negative regulators of cell proliferation p53 and Rb (38). However,
elevated E6 and E7 protein levels are associated with malignant
progression (39-41), and hence their levels need to be kept low for a
productive viral life cycle. A fine balance between activation and
repression of the early promoter P105 is essential.
The order in which the E2 binding sites on the genome are occupied
depends on both the intrinsic affinity of the E2-DNA interaction at
each site and the cooperativity of E2 binding to multiple sites. The
HPV-18 E2 protein binds with the highest affinity to BS4 and with
reduced affinity to sites BS1 and BS2 (1). Modulation of this intrinsic
affinity by cooperative binding to BS1 and BS2 does not alter the order
of E2BS occupancy as evidenced by footprinting experiments conducted on
the HPV-18 long control region (1), which included all four E2BS. It is
likely that at low concentrations of E2, E2BS4 is occupied and
P105 is activated. As E2 concentrations rise,
P105 repression occurs, concomitant with BS1 and BS2
occupancy. E2 bound to BS4 could continue to counteract total
repression of transcription and ensure that the E6 and E7 proteins are
expressed at a level appropriate to maintain a replication-competent
cellular environment (3).
Recognition of DNA sequence-dependent conformational
propensities contributes to the ability of the E2 proteins to
discriminate among consensus E2 binding sites present on the viral
genomes. Thus, the physico-chemical properties of the E2 proteins are
uniquely tailored for optimal regulation of gene expression and replication.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Zippora Shakked (Weizmann
Institute, Israel) and Dr. Michael Brenowitz (Albert Einstein
College of Medicine, NY) for helpful discussions and for critical
reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by Grant CA66964 from the National
Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1F9F) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
To whom correspondence should be addressed: Dept. of Biochemistry
and Program in Structural Biology, New York University Medical Center,
Skirball Institute of Biomolecular Medicine, 540 First Ave., New York,
NY 10016. E-mail: rashmi@saturn.med.nyu.edu.
Published, JBC Papers in Press, July 20, 2000, DOI 10.1074/jbc.M004541200
 |
ABBREVIATIONS |
The abbreviations used are:
E2BS, E2 binding
site;
HPV, human papillomavirus;
BPV, bovine papillomavirus;
DTT, dithiothreitol.
 |
REFERENCES |
| 1.
|
Steger, G.,
and Corbach, S.
(1997)
J. Virol.
71,
50-58
|
| 2.
|
Garrido-Guerrero, E.,
Carrillo, E.,
Guido, M.,
Zamorano, R.,
Garcia-Carranca, A.,
and Gariglio, P.
(1996)
Arch. Med. Res.
27,
389-394
|
| 3.
|
Cheng, S.,
Schmidt-Grimminger, D.-C.,
Murant, T.,
Broker, T.,
and Chow, T. L.
(1995)
Genes Dev.
9,
2335-2349
|
| 4.
|
Rapp, B.,
Pawellek, A.,
Kraetzer, F.,
Schaefer, M.,
May, C.,
Purdie, K.,
Grassmann, K.,
and Iftner, T.
(1997)
J. Virol.
71,
6956-6966
|
| 5.
|
Grassmann, K.,
Rapp, B.,
Maschek, H.,
Petry, K. U.,
and Iftner, T.
(1996)
J. Virol.
70,
2339-2349
|
| 6.
|
DiLorenzo, T. P.,
Chen, D.,
Zhang, P.,
and Steinberg, B. M.
(1998)
Virology
243,
130-139
|
| 7.
|
DiLorenzo, T. P.,
and Steinberg, B. M.
(1995)
J. Virol.
69,
6865-6872
|
| 8.
|
zur Hausen, H.,
and de Villiers, E. M.
(1994)
Annu. Rev. Microbiol.
48,
427-447
|
| 9.
|
zur Hausen, H.
(1996)
Biochim. Biophys. Acta
1288,
F55-F78
|
| 10.
|
Alexander, K. A.,
and Phelps, W. C.
(1996)
Biochemistry
35,
9864-9872
|
| 11.
|
Bedrosian, C. L.,
and Bastia, D.
(1990)
Virology
174,
557-575
|
| 12.
|
Hines, C. S.,
Meghoo, C.,
Shetty, S.,
Biburger, M.,
Brenowitz, M.,
and Hegde, R. S.
(1998)
J. Mol. Biol.
276,
809-818
|
| 13.
|
Li, R.,
Knight, J.,
Bream, G.,
Stenlund, A.,
and Botchan, M.
(1989)
Genes Dev.
3,
510-526
|
| 14.
|
Hegde, R. S.,
Wang, A.-F.,
Kim, S.-S.,
and Schapira, M.
(1998)
J. Mol. Biol.
276,
797-808
|
| 15.
|
Hegde, R. S.,
and Androphy, E. J.
(1998)
J. Mol. Biol.
284,
1479-1489
|
| 16.
|
Bussiere, D. E.,
Kong, X.,
Egan, D. A.,
Walter, K.,
Holzman, T. F.,
Lindh, F.,
Robins, T.,
and Giranda, V. L.
(1998)
Acta Crystallogr. D Biol. Crystallogr.
54,
1367-1376
|
| 17.
|
Hegde, R. S.,
Grossman, S. R.,
Laimins, L. A.,
and Sigler, P. B.
(1992)
Nature
359,
505-512
|
| 18.
|
Otwinowski, Z.
(1993)
in
Data Collection and Processing
(Sawyer, L.
, Isaacs, N.
, and Bailey, S., eds)
, pp. 56-62, SERC Daresbury Laboratory, Warrington, UK
|
| 19.
|
Navaza, J.
(1994)
Acta Crystallogr. A
50,
157-163
|
| 20.
|
Brunger, A.
(1992)
CNS, version 0.9
, Yale University Press, New Haven, CT
|
| 21.
|
Senear, D. F.,
and Brenowitz, M.
(1991)
J. Biol. Chem.
266,
13661-13671
|
| 22.
|
Senear, D. F.,
Dalma-Weishaus, D.,
and Brenowitz, M.
(1993)
Electrophoresis
14,
704-712
|
| 23.
|
Liang, H.,
Petros, A. M.,
Meadows, R. P.,
Yoon, H. S.,
Egan, D. A.,
Walter, K.,
Holzman, T. F.,
Robins, T.,
and Fesik, S. W.
(1996)
Biochemistry
35,
2095-2103
|
| 24.
|
Merkel, J. S.,
Sturtevant, J. M.,
and Regan, L.
(1999)
Struct. Fold Des.
17,
1333-1343
|
| 25.
|
Merkel, J. S.,
and Regan, L.
(1998)
Fold Des.
3,
449-455
|
| 26.
|
Chen, G.,
and Stenlund, A.
(2000)
J. Virol.
74,
1506-1512
|
| 27.
|
Berg, M.,
and Stenlund, A.
(1997)
J. Virol.
71,
3853-3863
|
| 28.
|
Thain, A.,
Webster, K.,
Emery, D.,
Clarke, A. R.,
and Gaston, K.
(1997)
J. Biol. Chem.
272,
8236-8242
|
| 29.
|
Crothers, D. M.,
Haran, T. E.,
and Nadeau, J. G.
(1990)
J. Biol. Chem.
265,
7093-7096
|
| 30.
|
Bostock-Smith, C. E.,
Laughton, C. A.,
and Searle, M. S.
(1999)
Biochem. J.
342,
125-132
|
| 31.
|
Rozenberg, H.,
Rabinovich, D.,
Frolow, F.,
Hegde, R. S.,
and Shakked, Z.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
15194-15199
|
| 32.
|
Olson, W. K.,
Gorin, A. A.,
Lu, X. J.,
Hock, L. M.,
and Zhurkin, V. B.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11163-11168
|
| 33.
|
Koudelka, G. B.,
Harbury, P.,
Harrison, S. C.,
and Ptashne, M.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4633-4637
|
| 34.
|
Koudelka, G. B.,
and Carlson, P.
(1992)
Nature
355,
89-91
|
| 35.
|
Duong, T. H.,
and Zakrzewska, K.
(1998)
J. Mol. Biol.
280,
31-39
|
| 36.
|
Stubenrauch, F.,
and Pfister, H.
(1994)
J. Virol.
68,
6959-6966
|
| 37.
|
Stubenrauch, F.,
Colbert, A. M.,
and Laimins, L. A.
(1998)
J. Virol.
72,
8115-23
|
| 38.
|
Vousden, K.
(1993)
FASEB J.
7,
872-879
|
| 39.
|
Schneider-Gadicke, A.,
and Schwarz, E.
(1986)
EMBO J.
5,
2285-2292
|
| 40.
|
Schneider-Gadicke, A.,
and Schwarz, E.
(1987)
Hamatol. Bluttransfus.
31,
380-381
|
| 41.
|
Baker, C. C.,
Phelps, W. C.,
Lindgren, V.,
Braun, M. J.,
Gonda, M. A.,
and Howley, P. M.
(1987)
J. Virol.
61,
962-971
|
| 42.
|
Carson, M.
(1987)
J. Mol. Graphics
5,
103-106
|
| 43.
|
Abagyan, R. A.,
Totrov, M. M.,
and Kuznetsov, D. N.
(1994)
J. Comp. Chem.
15,
488-506
|
| 44.
|
Nicholls, A.,
Sharp, K. A.,
and Honig, B.
(1991)
Proteins Struct. Funct. Genet.
11,
281-296
|
| 45.
|
Dickerson, R. E.
(1998)
Nulceic Acids Res.
26,
1906-1926
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. U. Ferreiro, I. E. Sanchez, and G. de Prat Gay
Transition state for protein-DNA recognition
PNAS,
August 5, 2008;
105(31):
10797 - 10802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gao and J. Skolnick
DBD-Hunter: a knowledge-based method for the prediction of DNA-protein interactions
Nucleic Acids Res.,
July 1, 2008;
36(12):
3978 - 3992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Curuksu, K. Zakrzewska, and M. Zacharias
Magnitude and direction of DNA bending induced by screw-axis orientation: influence of sequence, mismatches and abasic sites
Nucleic Acids Res.,
April 1, 2008;
36(7):
2268 - 2283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. E. Sanchez, M. Dellarole, K. Gaston, and G. de Prat Gay
Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics
Nucleic Acids Res.,
February 11, 2008;
36(3):
756 - 769.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Hooley, V. Fairweather, A. R. Clarke, K. Gaston, and R. Leo Brady
The recognition of local DNA conformation by the human papillomavirus type 6 E2 protein
Nucleic Acids Res.,
September 1, 2006;
34(14):
3897 - 3908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. U. Ferreiro, M. Dellarole, A. D. Nadra, and G. de Prat-Gay
Free Energy Contributions to Direct Readout of a DNA Sequence
J. Biol. Chem.,
September 16, 2005;
280(37):
32480 - 32484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-J. Su, M. R. Tock, S. U. Egelhaaf, W. C. K. Poon, and D. T. F. Dryden
DNA bending by M.EcoKI methyltransferase is coupled to nucleotide flipping
Nucleic Acids Res.,
June 7, 2005;
33(10):
3235 - 3244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. T. R. Lima and J. L. Silva
Positive Contribution of Hydration on DNA Binding by E2c Protein from Papillomavirus
J. Biol. Chem.,
November 12, 2004;
279(46):
47968 - 47974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhang, Z. Xi, R. S. Hegde, Z. Shakked, and D. M. Crothers
Predicting indirect readout effects in protein-DNA interactions
PNAS,
June 1, 2004;
101(22):
8337 - 8341.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Zimmerman and L. J. Maher III
Solution measurement of DNA curvature in papillomavirus E2 binding sites
Nucleic Acids Res.,
September 1, 2003;
31(17):
5134 - 5139.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Schaal, W. G. Mallet, D. L. McMinn, N. V. Nguyen, M. M. Sopko, S. John, and B. S. Parekh
Inhibition of human papilloma virus E2 DNA binding protein by covalently linked polyamides
Nucleic Acids Res.,
February 15, 2003;
31(4):
1282 - 1291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Y. Hou, S.-Y. Wu, and C.-M. Chiang
Transcriptional Activity among High and Low Risk Human Papillomavirus E2 Proteins Correlates with E2 DNA Binding
J. Biol. Chem.,
November 15, 2002;
277(47):
45619 - 45629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hizver, H. Rozenberg, F. Frolow, D. Rabinovich, and Z. Shakked
DNA bending by an adenine-thymine tract and its role in gene regulation
PNAS,
June 28, 2001;
(2001)
151247298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Newhouse and S. J. Silverstein
Orientation of a Novel DNA Binding Site Affects Human Papillomavirus-Mediated Transcription and Replication
J. Virol.,
February 15, 2001;
75(4):
1722 - 1735.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Remaut, N. Safarov, S. Ciurli, and J. Van Beeumen
Structural Basis for Ni2+ Transport and Assembly of the Urease Active Site by the Metallochaperone UreE from Bacillus pasteurii
J. Biol. Chem.,
December 21, 2001;
276(52):
49365 - 49370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hizver, H. Rozenberg, F. Frolow, D. Rabinovich, and Z. Shakked
DNA bending by an adenine-thymine tract and its role in gene regulation
PNAS,
July 17, 2001;
98(15):
8490 - 8495.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|